Lido Advisors, LLC Eli Lilly & CO Put Options Transaction History

Lido Advisors, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $1.16 Million - $1.45 Million	1,600 Added 64.0%	4,100 $3.71 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $177,660 - $237,684	300 Added 13.64%	2,500 $1.94 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $315,114 - $371,478	600 Added 37.5%	2,200 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $217,350 - $299,650	500 Added 45.45%	1,600 $859,000
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $245,518 - $328,286	700 Added 175.0%	1,100 $515,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $128,620 - $149,868	400 New	400 $146,000

3,872

751M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.